Targeted Analysis of Cell-free Circulating Tumor DNA is Suitable for Early Relapse and Actionable Target Detection in Patients with Neuroblastoma.
Lodrini M, Graef J, Thole-Kliesch TM, Astrahantseff K, Sprüssel A, Grimaldi M, Peitz C, Linke RB, Hollander JF, Lankes E, Künkele A, Oevermann L, Schwabe G, Fuchs J, Szymansky A, Schulte JH, Hundsdörfer P, Eckert C, Amthauer H, Eggert A, Deubzer HE.
Lodrini M, et al. Among authors: lankes e.
Clin Cancer Res. 2022 May 2;28(9):1809-1820. doi: 10.1158/1078-0432.CCR-21-3716.
Clin Cancer Res. 2022.
PMID: 35247920